KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to -$83.0 million.

  • Bausch Health Companies' Cash from Investing Activities rose 18.63% to -$83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$513.0 million, marking a year-over-year decrease of 27.61%. This contributed to the annual value of -$454.0 million for FY2024, which is 78.83% up from last year.
  • As of Q3 2025, Bausch Health Companies' Cash from Investing Activities stood at -$83.0 million, which was up 17.00% from -$100.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cash from Investing Activities ranged from a high of $588.0 million in Q3 2021 and a low of -$1.9 billion during Q3 2023.
  • Over the past 3 years, Bausch Health Companies' median Cash from Investing Activities value was -$100.0 million (recorded in 2025), while the average stood at -$264.7 million.
  • Per our database at Business Quant, Bausch Health Companies' Cash from Investing Activities skyrocketed by 940.00% in 2021 and then plummeted by 3,464.15% in 2023.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Cash from Investing Activities stood at -$80.0 million in 2021, then tumbled by 70.00% to -$136.0 million in 2022, then declined by 8.82% to -$148.0 million in 2023, then tumbled by 35.14% to -$200.0 million in 2024, then grew by 18.63% to -$83.0 million in 2025.
  • Its Cash from Investing Activities was -$83.0 million in Q3 2025, compared to -$100.0 million in Q2 2025 and -$130.0 million in Q1 2025.